During the past decade, Nishi Eye Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nishi Eye Hospital" are "Glaucoma" (1 trials), "Ocular Hypertension" (1 trials), "Open Angle Glaucoma, Ocular Hypertension" (1 trials) and "Primary Open Angle Glaucoma, Ocular Hypertension" (1 trials). Many other conditions were trialed in "Nishi Eye Hospital" in a lesser frequency.

Most popular intervention types in "Nishi Eye Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "STN1012600 ophthalmic solution 0.002%" (2 trials), "Latanoprost ophthalmic solution 0.005%" (1 trials), "STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%" (1 trials), "Xalacom" (1 trials) and "Xalatan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nishi Eye Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nishi Eye Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nishi Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nishi Eye Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".